NYSEARCA:REVS Columbia Research Enhanced Value ETF (REVS) Price, Holdings, & News $25.94 +0.28 (+1.09%) As of 01/21/2025 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendHoldingsOwnershipRatings About Columbia Research Enhanced Value ETF (NYSEARCA:REVS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get REVS alerts:Sign Up Key Stats Today's Range$25.78▼$25.9650-Day Range$24.49▼$26.9952-Week Range$21.50▼$27.03Volume20,083 shsAverage Volume7,174 shsMarket Capitalization$46.69 millionAssets Under Management$63.20 millionDividend Yield1.85%Net Expense Ratio0.19%Aggregate RatingModerate Buy ETF OverviewThe Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.Read More… Columbia Research Enhanced Value ETF ExpensesTypeREVSLarge Cap ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.19%0.58%0.55%0.51%0.52%Other Expenses0.00%0.31%0.49%0.57%0.54%Total Expense0.19%0.65%0.71%0.73%0.71%Fee Waiver0.00%-0.26%-0.51%-0.66%-0.56%Net Expense0.19%0.62%0.61%0.58%0.59% Receive REVS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Columbia Research Enhanced Value ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address REVS ETF News HeadlinesColumbia Research Enhanced Real Estate ETFDecember 23, 2024 | investing.comREVS Columbia Research Enhanced Value ETFOctober 17, 2024 | seekingalpha.comDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute he steps back into the White House. Because if what’s in this leaked document is even half true (and trust me, it comes from a very, very credible source)... Trump’s first Executive Order would easily be the boldest, most mind-blowing and daring American initiative ANY U.S. President has launched in over 80 years. January 22, 2025 | Banyan Hill Publishing (Ad)FEPY ETF: Combining Income and Growth Opportunities for Canadian InvestorsOctober 2, 2024 | theglobeandmail.comColumbia Thermostat A CTFAXAugust 14, 2024 | morningstar.comThe Zacks Analyst Blog Highlights IBM, Amazon.com and MicrosoftAugust 13, 2024 | uk.finance.yahoo.comSee More Headlines REVS ETF - Frequently Asked Questions How have REVS shares performed this year? Columbia Research Enhanced Value ETF's stock was trading at $24.73 at the beginning of 2025. Since then, REVS stock has increased by 4.9% and is now trading at $25.94. View the best growth stocks for 2025 here. How do I buy shares of Columbia Research Enhanced Value ETF? Shares of REVS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Columbia Research Enhanced Value ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that Columbia Research Enhanced Value ETF investors own include The GEO Group (GEO), Global X SuperDividend REIT ETF (SRET), BlackRock Capital Investment (BKCC), British American Tobacco (BTI), Energy Transfer (ET), International Business Machines (IBM) and Annaly Capital Management (NLY). Fund Details IssuerColumbia Fund NameColumbia Research Enhanced Value ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:REVS Inception Date9/25/2019 Fund ManagerChristopher Lo, Jason Wang WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkBeta Advantage Research Enhanced U.S. Value Index CategorySize and Style FocusLarge Cap Development LevelDeveloped Markets RegionNorth America Number of Holdings319 Fund Statistics Assets Under Management$63.20 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorColumbia Management Investment Advisers, LLC CustodianThe Bank of New York Mellon Corporation DistributorALPS Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation TrusteeN/A Lead Market MakerJane Street Options OptionableN/A Short Interest7,800 shs Miscellaneous Outstanding Shares1,800,000Beta0.76 Creation Unit50,000 Creation Fee$500.00 Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Top 10 REVS HoldingsJPMorgan Chase & Co. (NYSE:JPM)Holding Weight: 5.72%Cisco Systems (NASDAQ:CSCO)Holding Weight: 3.58%Exxon Mobil (NYSE:XOM)Holding Weight: 2.82%Bank of America (NYSE:BAC)Holding Weight: 2.58%Bristol-Myers Squibb (NYSE:BMY)Holding Weight: 2.51%Philip Morris International (NYSE:PM)Holding Weight: 2.42%Medtronic (NYSE:MDT)Holding Weight: 2.40%Wells Fargo & Company (NYSE:WFC)Holding Weight: 2.09%Caterpillar (NYSE:CAT)Holding Weight: 1.86%RTX (NYSE:RTX)Holding Weight: 1.84%Full Holdings DetailsREVS Sector ExposureREVS Industry Exposure This page (NYSEARCA:REVS) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThe Crypto Secret Wall Street Doesn’t Want You to KnowThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Columbia Research Enhanced Value ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Columbia Research Enhanced Value ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.